| SECIS | Selenocysteine Insertion Sequence |
| ROS | Reactive Oxygen Species |
| GPX | Glutathione Peroxidases |
| GPX4 | Glutathione Peroxidase 4 |
| TXNRD/TrxRs | Thioredoxin Reductases |
| DIO | Iodothyronine Deiodinases |
| DIO1 | Type 1 Iodothyronine Deiodinase |
| DIO2 | Type 2 Iodothyronine Deiodinase |
| DIO3 | Type 3 Iodothyronine Deiodinase |
| SELENOP/SelP | Selenoprotein P |
| SELENOW | Selenoprotein W |
| SELENOS/SelS | Selenoprotein S |
| SELENOK | Selenoprotein K |
| SELENOM/SelM | Selenoprotein M |
| SELENON | Selenoprotein N |
| SelF | Selenoprotein F |
| SeNPs | Selenium Nanoparticles |
| NKG2D | Natural Killer Group 2 Member D |
| ULBP2 | UL16 Binding Protein 2 |
| MSA | Methylseleninic Acid |
| BCL-2 | B-cell Lymphoma 2 |
| BAX | BCL-2 Associated X Protein |
| NO | Nitric Oxide |
| MDA | Malondialdehyde |
| GSH | Glutathione |
| SOD | Superoxide Dismutase |
| MAPK | Mitogen-Activated Protein Kinase |
| MAPK/ERK | Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase |
| SK-BR-3 | Trastuzumab-Sensitive Breast Cancer Cell Line |
| JIMT-1 | Trastuzumab-Resistant Breast Cancer Cell Line |